PBE ETF
$80.22
Invesco Biotechnology and Genome ETF
AUM$248M
TER0.58%
Holdings33

✓All holdings
✓Overlap Analysis
✓ETF Screener
✓Compare ETFs
Showing 10 of 33 holdings(as of Dec 31, 2025)Top 10 Weight: 46.30%
PBE ETF Top Holdings
PBE holdings top 10 positions. The top 10 holdings account for 46.3% of the fund, led by Illumina, Inc. at 5.1%, United Therapeutics Corp at 5.0%, Regeneron Pharmaceuticals, Inc. at 5.0%.
PBE portfolio concentration is moderate, with the top 10 representing 46.3% of total assets. The largest sector exposure is Health Care at 94.7%.
PBE sector allocation provides a detailed breakdown. PBE overlap tool shows how holdings compare to other funds in your portfolio.